Pfizer (PFE) Tops Q3 EPS by 14c, Beats on Revenue; Offers FY26 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. HNGE
8. MTCH
9. CVI
10. INSP

Go back to Pfizer (PFE) Tops Q3 EPS by 14c, Beats on Revenue; Offers FY26 Guidance

Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance

November 3, 2026 6:45 AM EST

Focused Execution Drove 32% Operational Revenue Growth of Launched and Acquired Products(1) Advancing Robust Late-Stage Pipeline with Multiple Key Catalysts Ahead Raises 2026 Guidance(2) on Strong Year-to-Date Performance Appoints Cecile Guegan Chief Financial Officer, Executive Vice President

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2026 and raised its full-year 2026 guidance(2) for both Revenues and Adjusted(3) diluted EPS.

EXECUTIVE COMMENTARY

Dr. Albert Bourla, Chairman and CEO of Pfizer:

"Pfizer had another strong quarter... More